Scientific Publications: 2003

  1. Tassaneetrithep B, Burgess T, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller M, Pattanapanyasat K, Sarasombath S, Birx D, Steinman R, Schlesinger S, and M Marovich. _DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells_ J Exp Med. 2003;197(7):823-9
  2. Currier JR, Dowling WE, Wasunna KM, Alam U, Mason CJ, Robb ML, Carr JK, McCutchan FE, Birx DL, Cox JH. Detection of High Frequencies of HIV-1 Cross-Subtype Reactive CD8 T Lymphocytes in the Peripheral Blood of HIV-1 Infected Kenyans. AIDS 17: 2149-2157. 2003.
  3. Pitisuttithum P, Nitayaphan S, Thongcharoen P, Khamboonruang C, Kim JH, deSouza MS, Chuenchitra T, Garner R, Thapinta D, Polonis VR, Kim S, Chanbancherd P, Chiu J, Birx DL, Duliege AM, McNeil JG, Brown AE, and the Thai AIDS Vaccine Evaluation group. Safety and immunogenicity of combinations of recombinant subtype E and B HIV-1 envelope gp120 vaccines in healthy Thai adults, J. Inf. Dis. 188:219-227, 2003.
  4. Kim JH, Mascola JR, Frankel S, de Souza MS, Chuenchitra T, Polonis VR, McLinden R, Sambor A, Brown AE, Pitisuttithum P, Phonrat B, Kamboonruang C, Rungruengthanakit K, Duliege A-M, Robb ML, McNeil J, Birx DL, and the Thai AIDS Vaccine Evaluation Group. Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: Detection of homologous and heterologous neutralizing antibody to subtype E HIV-1, AIDS Res and Hum Retroviruses 19:807-816, 2003.
  5. Carrión G, Hierholzer J, Montano S, Alava A, Perez J, Guevara A, Laguna-Torres V, Mosquera C, Russell K, Cruz C, Chauca G, Kochel T, Birx DL, Sanchez JL, Carr JK. Sequence Note: Circulating Recombinant Form CRF02_AG in South America. AIDS Research & Human Retroviruses 2003; 19:329-332.
  6. Polonis VR, de Souza MS, Chantakulkij S, Darden JM, Chuenchitra T, Nittayaphan S, Garner R, Brown AE, and Birx DL. Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and declining CD4 cell counts in subtype CRF01_AE infected patients.. J Virol, 2003. 77(15): p. 8570-6.
  7. Chowdhury IH, Farhadi A, Wang X, Robb ML, Birx DL, Kim JH. Human T Cell Leukemia Virus Type (HTLV-1) Tax Activates Cyclin Dependent Kinase Inhibitor (CDKI) Wafl/p21 Expression Through a p53-Independent Mechanism: Inhibition of cdk2. Int J Cancer, 2003. 107(4): p. 603-11.
  8. Sateren WB, Renzullo PO, Carr JK, Birx DL, McNeil JG. HIV-1 infection among civilian applicants for U.S. Military Service, 1985 to 2000: Epidemiology and geography. JAIDS 32:215-222. 2003.
  9. Tovanabutra S, Watanveeradej V, Viputtikul K, De Souza M., Razak MH, Suriyanon, Jittiwutikarn J, Sriplienchan S, Nitayaphan S, Benenson MW, Sirisopana N, Renzullo PO, Brown AE, Robb, ML, Beyrer C, Celentano DD, McNeil JG, Birx DL, Carr JK, McCutchan FE. A new circulating recombinant form, CRF15_01/B, reinforces the linkage between IDU and heterosexual epidemics in Thailand. AIDS Res Hum Ret. 19(7):561-567. 2003.
  10. Watanaveeradej V, deSouza M, Benenson MW, Sirisopana N, Nitayaphan S, Chanbancherd P, Brown AE, Sanders-Buell E, Birx DL, McCutchan FE, Carr JK. Subtype C/CRF01_AE Recombinant HIV-1 found in Thailand. AIDS 17 (14):2138-2140. 2003.
  11. Chowdhury IH., Wang XF, Landau NR, Robb ML. Polonis VR, Birx DL, and Kim JH. HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: a potential mechanism of G2/M cell cycle arrest. 2003. Virology. Jan 20; 305(2):371-7.
  12. Ratto-Kim S, Loomis-Price LD, Aronson N, Grimes J, Hill C, Williams C, El Habib R, Birx DL, Kim JH. Comparison Between Env-Specific T-Cell Epitope Responses in HIV-1 Uninfected Adults Immunized with Combination of ALVAC-HIV (vCP205) Plus or Minus rgp160MN/LAI-2 and HIV-1 Infected Adults. JAIDS. 2003 32:17.
  13. Chuenchitra T, Wasi C, Louisirirojchanakul S, Nitayaphan S, Sutthent R, Cox JH, deSouza MS, Brown AE, Birx DL, and Polonis VR. A Longitudinal Study of Humoral Immune Responses in HIV-1 Subtype CRF01_AE (E) Infected Thai Patients with Different Rates of Disease Progression. AIDS Res. & Hu. Retr 2003 19(4) 293-305.
  14. Birx DL, McCutchan F, Robb M, McNeil J. "International HIV Vaccine Development: Lessons Learned in Thailand Applied to Regional Development in East Africa; Perpective from a Sponsor." Proc XIIIth Cent Gardes Symp 2003; 169-178.
  15. Marovich M, Mascola M, Eller M,Tassaneetrithep B, Anderson J, Jones C, Cox J, Robb M, Tasker S, El-Habib R, Gurunathan S, Steinman R, Birx D, and S Schlesinger. "ALVAC-HIV (vCP205) Loaded Autologous DC as an HIV Vaccine Strategy" Proc XIIIth Cent Gardes Symp 2003; 127-132.
  16. McCutchan, FE, Carr JK, Tovanabutra S, Yu XF, Beyrer C, Birx DL. HIV-1 and drug trafficking: viral strains illuminate networks and provide focus for interventions. NIDA Satellite sessions in association with the XIV International AIDS conference, Barcelona., in Effects of drug use and high-risk behavior on HIV transmission across national borders. 2003: Barcelona. p. 112-118.
  17. Dong, M., et al., Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system. J Virol, 2003. 77(5): p. 3119-30.
  18. Dow, G.S., T. Hudson, M. Vahey and M. Koenig . The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro. Malar J, 2003. 2(1): p. 14.
  19. Farquhar, C., et al., Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. J Infect Dis, 2002. 186(8): p. 1173-6.
  20. Lin, B., et al., Biological threat detection via host gene expression profiling. Clin Chem, 2003. 49(7): p. 1045-9.
  21. Marovich, M.A., et al., Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells. J Infect Dis, 2002. 186(9): p. 1242-52.
  22. Mascola, J.R., et al., Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies. J Virol, 2003. 77(19): p. 10348-56.
  23. O'Connell, R.J., et al., Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. J Clin Microbiol, 2003. 41(5): p. 2153-5.
  24. Pando MA, Maulen S, Weissenbacher M, Marone R, Duranti R, Martinez-Peralta L, Salomon H, Russell K, Negrete M, Sosa Estani S, Montano S, Sanchez JL, Avila MM. High human immunodeficiency virus type 1 seroprevalence in men who have sex with men in Buenos Aires, Argentina: risk factors for infection. Int J Epidemiol 2003; 32:735-740.
  25. Papathanasopoulos, M.A., et al., Full-length genome characterization of HIV type 1 subtype C isolates from two slow-progressing perinatally infected siblings in South Africa. AIDS Res Hum Retroviruses, 2003. 19(11): p. 1033-7.
  26. Russi, J.C., et al., Sexual transmission of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1 infections among male transvestite comercial sex workers in Montevideo, Uruguay. Am J Trop Med Hyg, 2003. 68(6): p. 716-20.
  27. Sekowski, J.W., K.P. O'Donnell, A.S. Khan, J.J. Valdes, M. Vahey, M. Nau, M. Khalil andM.E. Eldefrawi. Changes in Gene Expression after Exposure to Organophosphorus Agents, in Alternative Toxicological Methods, H.S.a.S.A. Katz, Editor. 2003, CRC Press: London. p. 413-428.
  28. Vahey, M.T., M. Nau, P. Silvera, J. Yalley-Ogunro, M. Taubman and M. Lewis. Patterns of gene expression in peripheral blood mononuclear cells of rhesus macaques infected with SIVmac251 and exhibiting differential rates of disease progression. AIDS Res Hum Retroviruses, 2003. 19(5): p. 369-87.
  29. Wright, P.F., et al., Detection of mucosal antibodies in HIV type 1-infected individuals. AIDS Res Hum Retroviruses, 2002. 18(17): p. 1291-300.
  30. Zuckerman RA, Whittington WLH, Celum CL, Collis T, Lucchetti A, Sanchez JL, Hughes JP, Sanchez JL, Coombs RW. Factors associated with oropharyngeal human immunodeficiency virus shedding. J Infect Dis 2003; 188:142-145.
  31. Ratto-Kim, A., Garner, R.P., Kim, J.H., Jagodzinski, L.L., Michael, N.L., Paris, R., Redfield, R.R., Birx, D.L.: Prospective analyses of HIV-1 specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1 seropositive cohort. JID 189:1988-1995, 2004.
  32. Salcedo, R., Zhang, X., Young, H.A., Michael, N., Wasserman, K., Ma, W.-H., Martins-Green, M., Murphy, W.J., and Oppenheim, J.J. 2003. Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells. Blood 2003: 1966-1977.
  33. Jagodzinski, L.L., Cooley, J.D., Weber, M., and Michael, N.L. 2003. Performance characteristics of human immunodeficiency virus (HIV-1) genotyping systems in sequence-based analysis of non-B HIV-1 subtypes. J. Clin. Micro. 41: 998-1003.
  34. O'Connell, R.J., Merritt, T.M., Malia, J.A., VanCott, T.C., Dolan, M.J., Zahwa, H., Bradley, W.P., Branson, B.M., Michael, N.L., and De Witt, C.C. 2003. HAART reduces the sensitivity of OraQuick HIV 1/2, a developmental test device using a gp41 peptide for rapid HIV antibody detection in oral fluids or serum. J. Clin. Micro: 41, 2153-2155.
  35. Brodine SK, Starkey MJ, Shaffer RA, Ito SI, Tasker SA, Barile AJ, Tamminga CL, Stephan KT, Aronson NE, Fraser SL, Wallace MR, Wegner SA, Mascola JR, McCutchan FE. Diverse HIV-1 subtypes and clinical, laboratory, and behavioral factors in a recently infected US Military cohort. AIDS 17:2521-2527, 2003.
  36. Harris ME, Maayan S, Kim B, Zeira M, Ferrari G, Birx DL, McCutchan FE. A cluster of HIV-1subtype C sequences from Ethiopia, observed in full-genome analysis, is not sustained in sub-genomic regions. AIDS Res. and Human Retroviruses 19:1125-1133. 2003.
  37. Wilbe K, Salminen M, Laukkanen T, McCutchan F, Ray SC, Albert J, Leitner T. Characterization of novel recombinant HIV-1 genomes using the branching index. Virology 316:116-125.2003.
  38. Sanchez JL, Horosko S. Military and public health aspects of natural disasters. Military Preventive Medicine: Mobilization and Deployment. Vol 2. In: Textbook of Military Medicine. Washington, DC: US Army Surgeon General and the Borden Institute, 2003.
  39. Sanchez JL. Cholera and Shigellosis. Diseases spread by food, water, and soil. Military Preventive Medicine: Mobilization and Deployment. Vol 2. In: Textbook of Military Medicine. Washington, DC: US Army Surgeon General and the Borden Institute, 2003.
  40. Chanbancherd P, Paris RM, Torugsa K, de Souza M, Myint KSA, Chitpong A and Brown AE 2003. High Frequency of HIV-1 and Hepatitis C Co-infection among Young Thai Men: Evidence for a Changing Pattern of HIV Transmission in Thailand. Southeast Asian J Trop Med Public Health 34:580.